Literature DB >> 19320191

Expression of hepatocyte nuclear factor-1beta in human urogenital tract during the embryonic stage.

Noriko Kato1, Teiichi Motoyama.   

Abstract

OBJECTIVE: To investigate hepatocyte nuclear factor-1beta (HNF-1beta) expression in the human urogenital tract during the embryonic stage. STUDY
DESIGN: Twelve human fetuses (2 fetuses of undetermined sex, 5 males and 5 females) were immunohistochemically examined for HNF-1beta expression.
RESULTS: In the metanephric kidney (metanephros), the renal tubule was selectively positive for HNF-1beta. HNF-1beta expression was detected in mesonephric (wolffian) duct derivatives, including the efferent duct or epididymis, in fetuses at the 12th, 21st and 22nd gestational weeks, but not detected in the müllerian duct derivatives, including the uterus or fallopian tube, infetuses after the 18th gestational week. HNF-1beta was also expressed in remnants of the mesonephric tubule or duct lying in the mesovarium or mesosalpinx, not only in the fetus but also in the adult female (35-82 years old).
CONCLUSION: The present study indicates that HNF-1beta is involved in the development of mesonephric duct derivatives and metanephros and that HNF-1beta expression is conserved in the mesonephric duct remnants throughout life. Uncommon HNF-1beta expression in müllerian duct derivatives implies that involvement of HNF-1beta in the müllerian duct system is limited to a specific embryonic period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320191

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  5 in total

1.  Genome-wide association study identifies a common variant associated with risk of endometrial cancer.

Authors:  Amanda B Spurdle; Deborah J Thompson; Shahana Ahmed; Kaltin Ferguson; Catherine S Healey; Tracy O'Mara; Logan C Walker; Stephen B Montgomery; Emmanouil T Dermitzakis; Paul Fahey; Grant W Montgomery; Penelope M Webb; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Diether Lambrechts; Lieve Coenegrachts; Ignace Vergote; Frederic Amant; Helga B Salvesen; Jone Trovik; Tormund S Njolstad; Harald Helland; Rodney J Scott; Katie Ashton; Tony Proietto; Geoffrey Otton; Ian Tomlinson; Maggie Gorman; Kimberley Howarth; Shirley Hodgson; Montserrat Garcia-Closas; Nicolas Wentzensen; Hannah Yang; Stephen Chanock; Per Hall; Kamila Czene; Jianjun Liu; Jingmei Li; Xiao-Ou Shu; Wei Zheng; Jirong Long; Yong-Bing Xiang; Mitul Shah; Jonathan Morrison; Kyriaki Michailidou; Paul D Pharoah; Alison M Dunning; Douglas F Easton
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

2.  HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study.

Authors:  Vincenzo Dario Mandato; Enrico Farnetti; Federica Torricelli; Martino Abrate; Bruno Casali; Gino Ciarlini; Debora Pirillo; Maria Carolina Gelli; Davide Nicoli; Mario Grassi; Giovanni Battista LA Sala; Stefano Palomba
Journal:  BMC Cancer       Date:  2015-04-07       Impact factor: 4.430

3.  Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.

Authors:  Wei-Ting Chao; Chia-Hao Liu; Chiung-Ru Lai; Yi-Jen Chen; Chi-Mu Chuang; Peng-Hui Wang
Journal:  J Ovarian Res       Date:  2018-06-22       Impact factor: 4.234

4.  Urinary proteome signature of Renal Cysts and Diabetes syndrome in children.

Authors:  Pierbruno Ricci; Pedro Magalhães; Magdalena Krochmal; Martin Pejchinovski; Erica Daina; Maria Rosa Caruso; Laura Goea; Iwona Belczacka; Giuseppe Remuzzi; Muriel Umbhauer; Jens Drube; Lars Pape; Harald Mischak; Stéphane Decramer; Franz Schaefer; Joost P Schanstra; Silvia Cereghini; Petra Zürbig
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

5.  Hepatocyte Nuclear Factor-1β Induces Redifferentiation of Dedifferentiated Tubular Epithelial Cells.

Authors:  Mitsugu Omata; Yukiko Doke; Chikaomi Yamada; Kayoko Kawashima; Rumiko Sho; Kei Enomoto; Mayumi Furuya; Norio Inomata
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.